Isotretinoin therapy: Any need for laboratory assessment?

West African Journal of Medicine

Volumn 23, Issue 4, 2004, Pages 273-275

  Tallab, T ^a   Joharji, H ^b   Jazei, M ^b   Bahamdan, K ^a   Ibrahim, K ^b   Karkashan, E ^b  

^a KING KHALID UNIVERSITY   (Saudi Arabia)

^b ASEER CENTRAL HOSPITAL   (Saudi Arabia)

Author keywords

Acne vulgaris; Isotretinoin

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; ISOTRETINOIN; TRIACYLGLYCEROL;

ACNE VULGARIS; ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; REFERENCE VALUE; RETROSPECTIVE STUDY; SEX RATIO; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

ACNE VULGARIS; ADOLESCENT; ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; CHOLESTEROL; DRUG MONITORING; FEMALE; HUMANS; ISOTRETINOIN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 14244262145     PISSN: 0189160X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Saurat JH. Oral Isotretinoin. Where now, where next. Dermatology 1997: 195 (suppl 1): 1-3.
2. Meigel WN, How safe is Isotretinoin? Dermatology 1997; 195 (suppl 1): 22-8.
3. Goulden V. Layton AM. Cunliffe W. Long-term safety of Isotretinoin as a treatment for acne vulgaris., Br J Dermatol 1994; 131:360-3.
4. Ortonne JP, Oral Isotretinoin treatment policy. Do we all agree? Dermatology 1997; 195 (suppl 1) 34-7.
5. Barth JH, Macdonald-Hull SP, Mark J et al, Isotretinoin therapy for acne vulgaris: a re-evaluation of the need for measurement of plasma lipids and liver function tests. Br J Dermatol 1993; 129:704-7.
6. Alcalay J, Landan M, Zucker A. Analysis of laboratory in acne patients treatment with isotretinoin. Is there really a need to perform routine laboratory tests?. J Dermatology Treat 2001, March 12(1):9-12
7. Sadick N. A practitioner's 10-year experience with isotretinoin and side effect profiles. International Journal of Cosmetic Surgery and Aesthetic Dermatology, Vol. 4, Number 2, 2002.
8. Dominguez-Munoz JE, Junemann F. Malfertheiner P. Hyperlipidemia in acute pancreatitis. Cause or epiphenomenon? Int J Pancreatol 1995; 18:101-6.
9. Lestingant GG, Frossard PM, Agarwal M, Galadari IH. Variations in lipid and lipoprotein levels during isotretinoin treatment for acne vulgaris with special emphasis on HDL-cholesterol. Int J Dermatol 1997; 3:859-62.